日本語 
Pharma
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains setmelanotide, which helps patients who have acquired obesity. The launch is possible because the medicine was added to…
Austria and Germany First in EU to Launch LEQEMBI
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
JDSC launches Smart Factory for pharma manufacturing
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
Elix Provides AI Drug Discovery Platform “Elix DiscoveryTM” to KYORIN Pharmaceutical
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Eisai’s Insomnia drug DAYVIGO approved for Use in China
Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s…
PADCEV + KEYTRUDA improve Survival in Bladder Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Nxera Launches Pipeline for Obesity, Weight Management
Nxera Pharma has launched a wide range of unique treatments. These aim…
Lantern Pharma completes LP-300 Lung cancer trial signup
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies…
Protagenic Gets Japan Patent for Stilbenoid Drug Program
Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent…
Austria and Germany First in EU to Launch LEQEMBI
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
JDSC launches Smart Factory for pharma manufacturing
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
Elix Provides AI Drug Discovery Platform “Elix DiscoveryTM” to KYORIN Pharmaceutical
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Eisai’s Insomnia drug DAYVIGO approved for Use in China
Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s…
PADCEV + KEYTRUDA improve Survival in Bladder Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Nxera Launches Pipeline for Obesity, Weight Management
Nxera Pharma has launched a wide range of unique treatments. These aim…
Lantern Pharma completes LP-300 Lung cancer trial signup
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies…
Protagenic Gets Japan Patent for Stilbenoid Drug Program
Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent…
English